A Relative Bioavailability Study of Moexipril HCl 15 mg Tablets Under Fasting Conditions

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2009
The purpose of this study is to compare the relative bioavailability of Moexipril HCl 15mg tablets (by Paddock Laboratories, Inc.) with that of Univasc® 15mg tablets (by Schwarz Pharma) following a single oral dose (1 x 15mg tablet) in healthy, adult subjects under fasting conditions.
Epistemonikos ID: 934cf4205e9fccec84ebb51afc89a0d2489f8d13
First added on: May 05, 2024